Cargando…

单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究

BACKGROUND AND OBJECTIVE: In recent years, with the advancement of minimally invasive techniques, thoracoscopic thymoma resection has experienced a development process from three-port video-assisted thoracic surgery (VATS) to two-port (TP) and single-port (SP) variants. However, the feasibility and...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051302/
https://www.ncbi.nlm.nih.gov/pubmed/35477189
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.15
_version_ 1784696522331389952
collection PubMed
description BACKGROUND AND OBJECTIVE: In recent years, with the advancement of minimally invasive techniques, thoracoscopic thymoma resection has experienced a development process from three-port video-assisted thoracic surgery (VATS) to two-port (TP) and single-port (SP) variants. However, the feasibility and safety of SP-VATS have not been generally recognized. This study intends to explore the safety and feasibility of SP-VATS in thymoma resection, in order to provide a reference for clinical surgicalselection. METHODS: The clinical data of 197 patients who underwent thoracoscopic thymoma resection in Beijing Tongren Hospital from January 2018 to September 2021 were retrospectively analyzed. The patients were divided into SP-VATS group (n=42) and TP-VATS group (n=155). After matching propensity scores, there is no statistically significant difference in preoperative baseline data between SP-VATS group and TP-VATS group. Among them, there were 17 males and 25 females with an average age of 28-72 (48.00±9.43) years in the SP-VATS group, and 20 males and 22 females with an average age of 30-75 (50.38±9.83) years in TP-VATS group. The clinical effects of the two groups were compared. RESULTS: The operation was successfully completed in both groups, and there was no conversion to thoracotomy or increased surgical incisions. Compared with the TP-VATS group, the chest drainage time and hospital stay in the SP-VATS group were shorter [(2.95±0.76) d vs (3.33±0.85) d; (4.57±0.83) d vs (5.07±1.13) d], and the visual pain score at 24 h and 72 h after surgery were lower [(3.64±0.85) points vs (4.05±0.66) points; (2.33±0.75) points vs (3.07±0.68) points] (P < 0.05). There was no statistically significant difference between the two groups in operation time [(130.00±26.23) min vs (135.24±27.03) min], intraoperative blood loss [(69.52±22.73) mL vs (82.38±49.23) mL] (P > 0.05). CONCLUSION: SP-VATS in thymoma is a safe, feasible, and less invasive procedure, with less postoperative pain and faster recovery than multi-port VATS.
format Online
Article
Text
id pubmed-9051302
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-90513022022-05-11 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: In recent years, with the advancement of minimally invasive techniques, thoracoscopic thymoma resection has experienced a development process from three-port video-assisted thoracic surgery (VATS) to two-port (TP) and single-port (SP) variants. However, the feasibility and safety of SP-VATS have not been generally recognized. This study intends to explore the safety and feasibility of SP-VATS in thymoma resection, in order to provide a reference for clinical surgicalselection. METHODS: The clinical data of 197 patients who underwent thoracoscopic thymoma resection in Beijing Tongren Hospital from January 2018 to September 2021 were retrospectively analyzed. The patients were divided into SP-VATS group (n=42) and TP-VATS group (n=155). After matching propensity scores, there is no statistically significant difference in preoperative baseline data between SP-VATS group and TP-VATS group. Among them, there were 17 males and 25 females with an average age of 28-72 (48.00±9.43) years in the SP-VATS group, and 20 males and 22 females with an average age of 30-75 (50.38±9.83) years in TP-VATS group. The clinical effects of the two groups were compared. RESULTS: The operation was successfully completed in both groups, and there was no conversion to thoracotomy or increased surgical incisions. Compared with the TP-VATS group, the chest drainage time and hospital stay in the SP-VATS group were shorter [(2.95±0.76) d vs (3.33±0.85) d; (4.57±0.83) d vs (5.07±1.13) d], and the visual pain score at 24 h and 72 h after surgery were lower [(3.64±0.85) points vs (4.05±0.66) points; (2.33±0.75) points vs (3.07±0.68) points] (P < 0.05). There was no statistically significant difference between the two groups in operation time [(130.00±26.23) min vs (135.24±27.03) min], intraoperative blood loss [(69.52±22.73) mL vs (82.38±49.23) mL] (P > 0.05). CONCLUSION: SP-VATS in thymoma is a safe, feasible, and less invasive procedure, with less postoperative pain and faster recovery than multi-port VATS. 中国肺癌杂志编辑部 2022-04-20 /pmc/articles/PMC9051302/ /pubmed/35477189 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.15 Text en 版权所有©《中国肺癌杂志》编辑部2022 https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 临床研究
单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
title 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
title_full 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
title_fullStr 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
title_full_unstemmed 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
title_short 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
title_sort 单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051302/
https://www.ncbi.nlm.nih.gov/pubmed/35477189
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.15
work_keys_str_mv AT dānkǒngyǔdāncāozuòkǒngxiōngqiāngjìngxiàxiōngxiànliúqièchúshùdelínchuángliáoxiàobǐjiàoyīxiàngqīngxiàngxìngpíngfēnpǐpèiyánjiū
AT dānkǒngyǔdāncāozuòkǒngxiōngqiāngjìngxiàxiōngxiànliúqièchúshùdelínchuángliáoxiàobǐjiàoyīxiàngqīngxiàngxìngpíngfēnpǐpèiyánjiū
AT dānkǒngyǔdāncāozuòkǒngxiōngqiāngjìngxiàxiōngxiànliúqièchúshùdelínchuángliáoxiàobǐjiàoyīxiàngqīngxiàngxìngpíngfēnpǐpèiyánjiū
AT dānkǒngyǔdāncāozuòkǒngxiōngqiāngjìngxiàxiōngxiànliúqièchúshùdelínchuángliáoxiàobǐjiàoyīxiàngqīngxiàngxìngpíngfēnpǐpèiyánjiū
AT dānkǒngyǔdāncāozuòkǒngxiōngqiāngjìngxiàxiōngxiànliúqièchúshùdelínchuángliáoxiàobǐjiàoyīxiàngqīngxiàngxìngpíngfēnpǐpèiyánjiū